PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
148 hedge funds and large institutions have $317M invested in Progenics Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
32% less call options, than puts
Call options by funds: $612K | Put options by funds: $896K
Holders
148
Holding in Top 10
–
Calls
$612K
Puts
$896K
Top Buyers
| 1 | +$7.15M | |
| 2 | +$5.33M | |
| 3 | +$4.76M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$3.38M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.92M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$14.5M | |
| 3 | -$5.12M | |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
-$2.56M |
| 5 |
Citigroup
New York
|
-$2.31M |